DM-235 hmoovyog cov hmoov dawb crystalline hmoov, muaj zog piperazine zoo heev -raws li nootropic active tshuaj muaj nyob rau hauv tsev neeg Ampagin. Nws lub luag haujlwm tseem ceeb yog txhawm rau txhim kho kev paub thiab txhim kho kev nco, nrog kev ua tau zoo tshaj li ntawm cov tshuaj classic nootropic piracetam. Nws cov qauv molecular mimics cov chaw tswj hwm ntawm neurotransmitters, tso cai rau nws kom meej meej rau lub hlwb lub cev glutamatergic thiab cholinergic systems, zoo txhim kho synaptic plasticity thiab efficiency ntawm neural teeb liab kis tau tus mob.
🧪 Piperazine nucleus-raws li kev tsim kho ntawm cov nquag nquag neuroregulatory molecules
CovDM-235 hmoovmolecule muaj lub nplhaib piperazine raws li nws cov tub ntxhais, nrog benzoyl pawg txuas mus rau ib sab thiab propionyl pawg mus rau lwm qhov, tsim cov qauv sib xyaw thiab ruaj khov heterocyclic hloov pauv. Nws cov mis molecular yog C₁₄H₁₈N₂O₂, thiab nws qhov hnyav molecular yog 246.3. Lub nplhaib piperazine yog ib tug rau - koom nrog nitrogen- muaj heterocycle nrog ib tug tsis tu ncua atomic kev npaj thiab ib tug ruaj khov conjugated system. Nws tsis yooj yim rau kev tawg lossis rov kho dua ntawm chav tsev kub, ua kom muaj kev ruaj ntseg ntawm cov hmoov thaum lub sij hawm ntev - khaws cia ntawm qib molecular. Ob lub nitrogen atoms ntawm lub nplhaib tsim amide daim ntawv cog lus nrog cov benzoyl thiab propionyl pawg, feem, tsim ntau qhov chaw hydrogen bonds. Cov chaw no tuaj yeem txheeb xyuas tau meej thiab khi rau thaj chaw tseem ceeb ntawm lub hlwb NMDA thiab AMPA receptors, tsim cov qauv tsim rau nws cov teebmeem neuroregulatory.
Cov khoom siv raw li solubility yog tsim rau ntau hom tshuaj. DM-235 Powder muaj solubility ntawm 24 mg/mL hauv dej, yooj yim soluble hauv organic solvents xws li methanol thiab ethanol, thiab me ntsis soluble hauv hexane. Cov tshuaj aqueous yog ruaj khov thiab tsis degrade txawm tias tom qab ntev cia ntawm chav tsev kub. Nws yog nruab nrab nyob rau hauv pH thiab nthuav tawm zoo heev compatibility nrog feem ntau siv excipients nyob rau hauv lub qhov ncauj formulations, qhia tsis muaj nag lossis daus teeb meem. Cov molecules rhiab heev rau lub teeb; Lub hnub ci ncaj qha tuaj yeem ua rau cov pab pawg benzoyl oxidize thiab decompose, txo cov ntsiab lus ntawm cov khoom xyaw nquag. Yog li ntawd, raw khoom cia, formulation ntau lawm, thiab tiav cov khoom cia yuav tsum tau ua nyob rau hauv lub teeb-tiv thaiv, kaw ib puag ncig nrog lub ambient kub tswj hauv qab no 25 degree.
Los ntawm txoj kev pom kev ua hmoov, industrially uaDM-235 hmoovCrystals yog zoo thiab sib xws nyob rau hauv loj, nrog ib tug concentrated particle loj faib, ib tug me me lub kaum sab xis ntawm repose, thiab zoo heev flowability. Nyob rau hauv cov kab ntau lawm, thaum sib tov, granulation, ntsiav tshuaj, thiab tshuaj ntsiav filling txheej txheem, cov khoom thauj yog du, tsis muaj bridging, sticking, los yog agglomeration, ua rau nws haum rau siab - ceev automated ntau lawm khoom. Cov khoom siv raw muaj qis heev hygroscopicity; Txawm tias tom qab 24 lub hlis ntawm kev kaw cia hauv ib puag ncig nrog 70% txheeb ze av noo, cov hmoov tseem dawb thiab xoob, tsis pom kev tsis zoo lossis tsis muaj xim. Irreversible degradation ntawm cov molecule tsuas yog tshwm sim nyob rau hauv huab cua kub thiab muaj zog oxidants, simplifying niaj hnub cia thiab kev thauj mus los.
Cov khoom muaj kev nyab xeeb molecular yog txiav txim los ntawm nws cov qauv. DM-235 Powder yog ib qho kev xaiv modulator ntawm neuroreceptors, ua haujlwm tsuas yog nyob rau hauv lub glutamatergic thiab cholinergic systems ntawm lub hlwb. Nws yog non-toxic rau lub cev ib txwm muaj thiab tsis muaj cov khoom siv ntxiv lossis cov teebmeem tsis zoo ntawm cov tshuaj noj. Tom qab nkag mus rau tib neeg lub cev, cov tshuaj yog sai absorbed ntawm qhov ncauj nrog siab bioavailability. Nws yog feem ntau metabolized nyob rau hauv daim siab, tawg mus rau hauv inactive khoom, thiab feem ntau yog tawm los ntawm ob lub raum, tsis muaj kev pheej hmoo ntawm tsub zuj zuj nyob rau hauv lub cev. Ua ke nrog nws cov pob txha piperazine ruaj khov, zoo heev solubility, zoo heev hmoov ua kev ua tau zoo, thiab txhim khu kev qha kev ruaj ntseg, cov khoom siv tshuaj no yog cov khoom siv tseem ceeb tshaj plaws rau kev txhim kho kev txawj ntse.
⚙️ Tswj cov neural receptors los txhim kho synaptic plasticity thiab nco tsim
Tom qab kev tswj hwm qhov ncauj lossis sublingual,DM-235 hmoovsai hla cov ntshav- hlwb teeb meem thiab lub hom phiaj tseem ceeb ntawm lub hlwb ntawm lub hlwb, xws li hippocampus thiab cortex, precisely tswj ob lub ntsiab neurotransmitter systems: glutamatergic thiab cholinergic. Kev paub txog kev ua haujlwm nyob ntawm cov teeb liab kis ntawm cov neurons, thiab glutamate yog qhov tseem ceeb tshaj plaws excitatory neurotransmitter nyob rau hauv nruab nrab paj hlwb. Nws cov receptors (NMDA, AMPA) yog cov chaw tswj hwm tseem ceeb rau kev kawm, nco, thiab synaptic plasticity. DM-235 Powder, nrog nws daim ntawv molecular zoo ib yam li cov neurotransmitters, nyiam khi rau receptor active sites, pib ib txoj kev paub txog kev txawj ntse.
Ib zaug nyob rau hauv lub hlwb, DM-235 Hmoov feem ntau ua raws li qhov zoo allosteric regulator ntawm glycine binding site ntawm NMDA receptor, thaum indirectly txhim kho AMPA receptor kev ua. Nws ua raws li kev khi ntawm glycine rau NMDA receptors, ua kom cov receptor channels, txhawb calcium ion influx, thiab tom qab ntawd ua kom cov enzymes tseem ceeb xws li CaMKII thiab PKC, ntxiv dag zog rau kev sib txuas ntawm neuronal synaptic, thiab txhim kho synaptic plasticity-cov txheej txheem tseem ceeb ntawm kev nco thiab kev sib koom ua ke. Ib txhij, nws txhawb kev tso tawm ntawm acetylcholine nyob rau hauv lub paj hlwb cortex. Acetylcholine yog ib qho tseem ceeb neurotransmitter tswj kev saib xyuas, ua kom pom tseeb, thiab kev kawm muaj peev xwm, txhim kho cov ntaub ntawv kev ua tau zoo thiab kev mloog zoo.
Kev ua kom tsis ncaj ntawm AMPA receptors los ntawm DM-235 Powder txhim kho qhov ntev -lub sij hawm potentiation (LTP) cov nyhuv hauv CA1 cheeb tsam ntawm hippocampus. LTP yog cov txheej txheem physiological tseem ceeb rau neuronal synaptic ntxiv dag zog thiab tsim kom muaj lub cim xeeb ntev. Tsiaj thwmsim qhia tau hais tias nanomolar ntau ntawm DM-235 Powder tuaj yeem txhim kho LTP, deb tshaj qhov cuam tshuam ntawm piracetam, tsis muaj kev pheej hmoo ntawm excitatory toxicity. Los ntawm kev txhim kho LTP thiab txhawb kev tso tawm neurotransmitter, nws tuaj yeem txhim kho kev kawm ceev, txhim khu kev nco, thiab txhim kho kev txawj ntse, thaum tseem txo kev ntxhov siab thiab txhim kho lub siab thiab kev txhawb siab.
Cov txheej txheem ntawm kev txiav txim no ua rau pom qhov cuam tshuam tseem ceeb thoob plaws ntau yam kev paub txog kev paub. Thaum siv rau cov tib neeg noj qab haus huv, nws tuaj yeem txhim kho kom pom tseeb, kev nco, thiab kev puas siab puas ntsws, ua rau nws haum rau siab -kev siv zog, kev kawm, thiab kev xeem. Rau cov neeg mob uas muaj kev puas siab puas ntsws me me lossis thaum ntxov- kab mob Alzheimer, nws tuaj yeem ua rau lub hlwb qeeb qeeb thiab txhim kho cov tsos mob xws li tsis nco qab thiab tsis muaj zog. Rau cov tib neeg uas muaj kev ntxhov siab ntau dhau los yog kev ntxhov siab, nws tuaj yeem tswj hwm qhov sib npaug ntawm neurotransmitter, txo kev ntxhov siab, txhim kho kev xav, thiab txhim kho kev puas siab puas ntsws tag nrho - ua.
Cov tshuaj muaj ib tug meej metabolic atherosclerosis nyob rau hauv lub cev, ceev lub qhov ncauj nqus, thiab ib tug ceev pib ntawm kev txiav txim nrog ib tug nruab nrab lub sij hawm ntawm cov nyhuv; Cov tshuaj muaj txiaj ntsig zoo tuaj yeem tswj tau nrog 1-2 koob tshuaj txhua hnub. Cov metabolites tsis ua haujlwm, ua rau tsis muaj kev pheej hmoo ntawm kev txuam nrog, ua kom muaj kev nyab xeeb siab nrog kev siv sijhawm ntev -, thiab tshem tawm cov kev pheej hmoo ntawm kev tiv thaiv yeeb tshuaj lossis kev quav tshuaj. Tag nrho txoj hauv kev ntawm kev nqis tes ua yog xaiv tau zoo, ua haujlwm sai, thiab ua haujlwm tau zoo, ua rau nws tsim nyog rau kev paub txog kev txhim kho hauv cov tib neeg noj qab haus huv nrog rau kev cuam tshuam rau cov kab mob neurodegenerative, catering rau ntau yam kev paub txog kev xav tau kev txhim kho.
💊 Ntau- cov qauv tsim ntau npaum li cas npog cov ntawv thov kev paub txog kev txawj ntse thoob plaws txhua qhov xwm txheej
Cov ntsiav tshuaj ntawm qhov ncauj thiab cov tshuaj ntsiav nyuaj yog cov ntaub ntawv siv ntau tshaj plaws ntawmDM-235 hmoovthiab yog qhov kev xaiv tseem ceeb rau kev paub txog kev txawj ntse txhua hnub. Thaum lub sij hawm tsim khoom, cov ntaub ntawv raw yog tov nrog excipients xws li microcrystalline cellulose, lactose, thiab disintegrants, granulated, thiab ces compressed rau hauv ntsiav tshuaj los yog capsules. Daim ntawv txhaj tshuaj no yooj yim rau kev noj thiab muab cov koob tshuaj meej. Nws yog tsuas yog siv los txhim kho kev ua kom pom tseeb, nco, thiab kev muaj peev xwm kawm hauv cov tib neeg noj qab haus huv, thiab tseem tuaj yeem siv tau ntev - kev tswj xyuas cov neeg mob uas muaj kev puas hlwb me me. Nws yog dav siv hauv kev paub txog kev noj qab haus huv cov khoom lag luam thiab kev tshawb fawb neuroscience.
Cov ntsiav tshuaj sublingual yog ib daim ntawv nqus tau zoo heev uas tsim los rau qhov pib sai. High-cov ntaub ntawv purity raw yog tov nrog excipients xws li mannitol thiab flavoring agents thiab compressed rau hauv ntsiav tshuaj. Tom qab noj sublingually, lawv raug absorbed ncaj qha los ntawm lub qhov ncauj mucosa, zam thawj - dhau los ntawm daim siab, ua rau kom pib sai dua (15-30 feeb) thiab ntau dua bioavailability. Tsim nyog rau cov xwm txheej uas xav tau kev txawj ntse sai, xws li kev ua haujlwm siab, kev kuaj xyuas, thiab kev sib tw, nws yooj yim rau siv, ua rau tsis muaj kab mob plab, thiab yog daim ntawv ntau npaum li cas rau kev paub txog kev txawj ntse.
Kev ncua ntawm qhov ncauj yog ib qho sub- daim ntawv noj tshuaj tsom rau cov neeg uas muaj teeb meem nqos (xws li cov neeg laus thiab menyuam yaus). DM-235 hmoov yog tov nrog suspending agents, flavoring agents, thiab buffering excipients los tsim ib tug qhuav ncua kev kawm ntawv. Ua ntej siv, nws tuaj yeem shaken nrog dej sov los ua ib hom kev ncua. Kev noj tshuaj tuaj yeem raug kho raws li lub hnub nyoog thiab qhov hnyav, nrog kev ua kom zoo dua qub thiab ua raws li qhov zoo. Nws muaj kev siv dav hauv kev paub txog kev txawj ntse hauv cov neeg laus thiab kev txhim kho kev kawm hauv cov menyuam yaus.
- High -cov ntaub ntawv purity raw rau kev tshawb fawb yog cov cuab yeej tseem ceeb hauv kev tshawb fawb txog neuroscience.DM-235 hmoovnrog purity Ntau dua lossis sib npaug li 98% yog siv los ua kev tswj xyuas zoo los ntawm cov chaw tshawb fawb thiab chaw muag tshuaj R&D thoob ntiaj teb rau kev tshawb fawb txog glutamate receptor regulation, synaptic plasticity, thiab nco mechanisms. Hauv kev tsim tshuaj tshiab, nws ua haujlwm ua cov khoom siv lead ua rau kev tshuaj xyuas cov tshuaj nootropic, txheeb xyuas cov txheej txheem ntawm kev ua, thiab sib piv cov txiaj ntsig, ua rau nws yog ib qho khoom siv tsis tseem ceeb rau kev txhim kho kev paub txog tshuaj.
Combination formulations yog ib qho kev taw qhia tseem ceeb rau kev nthuav dav daim ntawv thov. DM-235 Powder yog kev tshawb fawb ua ke nrog cov khoom xws li B vitamins, Omega-3, thiab acetylcholine precursors los tsim cov khoom lag luam kev txawj ntse. Kev npaj ua ke tuaj yeem ua haujlwm sib koom ua ke los tiv thaiv lub paj hlwb, tswj cov metabolism, thiab txhim kho mus ob peb vas, ua tiav ob qho txiaj ntsig ntawm kev paub txog kev paub thiab kev noj qab haus huv. Lawv tsim nyog rau kev xav txog kev xav tau ntev ntev thiab muaj kev cia siab dav hauv kev lag luam ntxiv kev noj qab haus huv.
🔬 Technological iteration tsav lub teb ntawm kev paub txog kev txawj ntse
Txhim kho ntsuab synthesis txheej txheem yog ib qho tseem ceeb optimization kev taw qhia rau kev lag luam. Cov txheej txheem kev sib xyaw ua ke siv ntau cov organic solvents, uas ua rau muaj kuab paug loj thiab cov nqi siab. Tam sim no, kev lag luam tau txhawb nqa hnyav-dawb catalytic synthesis thiab nruam ntws cov tshuaj tiv thaiv technologies, siv ib puag ncig tus phooj ywg catalysts, simplifying cov txheej txheem tshuaj tiv thaiv, txo cov organic hnyav siv ntau tshaj 60%, thiab txo emissions. Cov txheej txheem tshiab, thaum ua kom cov khoom purity (Ntau dua lossis sib npaug li 98%) thiab siv lead ua daim ntawv ruaj khov, ua rau cov khoom tsim tawm ntau dua 85%, txo cov nqi tsim khoom, ua raws li thoob ntiaj teb GMP thiab cov qauv tshuaj ntsuab, thiab pab cov khoom siv raw khoom hauv tsev nthuav dav mus rau lub ntiaj teb siab -kawg lag luam.
Crystal daim ntawv tshuaj ntsuam thiab hmoov hloov tshuab txuas ntxiv mus. Cov ntaub ntawv tseem ceeb siv lead ua nthuav tawm me ntsis rau agglomerate nyob rau hauv qhov kub thiab txias ib puag ncig. Cov kws kho mob tau tshuaj xyuas cov tshuaj siv lead ua tshiab tshiab nrog kev ruaj ntseg zoo dua thiab ntws los ntawm cov kuab tshuaj -induced crystallization thiab gradient kub- tswj crystallization. Ib txhij, airflow micronization tshuab yog siv los tswj cov hmoov particle loj. Cov hmoov refined yog sib npaug sib npaug hauv cov formulations, txhim kho cov ntsiav tshuaj dissolution nqi thiab ncua kev kawm ntawv stability, zoo txhim kho zoo thiab txee lub neej ntawm downstream formulations.
Lub hom phiaj xa tshuaj tau dhau los ua ib qho kev txiav - kev tshawb fawb hotspot. Cov tshuaj hauv qhov ncauj tau muab faib thoob plaws hauv lub cev, thiab qee cov tshuaj tsis tuaj yeem hla cov ntshav - lub hlwb thaiv, ua rau muaj kev siv tsawg. Pab pawg tshawb fawb tau tsim cov neeg nqa khoom xws li liposomes thiab polymer nanoparticles, encapsulatingDM-235 hmoovrau lub hlwb xa mus. Lub hom phiaj cov neeg nqa khoom tuaj yeem txhim kho cov tshuaj permeability thoob plaws cov ntshav- lub hlwb teeb meem, nce cov tshuaj concentration hauv cov cheeb tsam kev txawj ntse xws li hippocampus thiab cortex, thiab txo cov kev faib tawm hauv cov ntaub so ntswg peripheral, yog li txhim kho kev ua tau zoo thaum txo cov kev mob tshwm sim. Ntau lub hom phiaj tsim tau twb tau nkag mus rau theem preclinical validation.
Txoj kev loj hlob ntawm ntev - ua kom ruaj khov - cov qauv tso tawm yog nce mus tsis tu ncua. Rau cov pej xeem uas xav tau ntev - lub sij hawm kev paub txog kev tswj hwm, txhawb nqa - tso tawm cov ntsiav tshuaj thiab txhawb nqa - tso tawm microspheres tau tsim. Kev siv cov polymeric sustained- tso tawm cov txheej txheem los yog biodegradable carriers, cov tshuaj tso tawm qeeb qeeb, cov ntshav cov tshuaj concentration yog stabilized, thiab lub sij hawm ntawm kev txiav txim yog ncua mus rau 8-12 teev, txo qhov zaus ntawm koob tshuaj thiab txhim kho lub sij hawm ntev - noj cov tshuaj. Sustained-tso tawm formulations zam kev hloov pauv hauv cov ntshav cov tshuaj concentration, maj mam txhim kho kev txawj ntse thiab tsim nyog rau kev kho mob mus sij hawm ntev xws li kev puas hlwb me me thiab kev cuam tshuam ntxov rau Alzheimer's disease.
Xaus
DM-235 Powder, nrog rau nws qhov tshwj xeeb piperazine core molecular qauv, meej lub hom phiaj NMDA thiab AMPA receptors hauv lub hlwb, txhim kho synaptic plasticity thiab txhawb kev tso tawm neurotransmitter kom ua tiav cov txiaj ntsig kev paub txog kev txawj ntse, deb tshaj qhov ua tau zoo ntawm cov tshuaj nootropic. Leveraging nws zoo heev physicochemical zog thiab formulation compatibility, nws muaj nyob rau hauv ntau npaum li cas cov ntaub ntawv, nrog rau qhov ncauj ntsiav tshuaj, sublingual ntsiav tshuaj, thiab ncua kev kawm ntawv, comprehensively npog cov xwm txheej xws li kev txawj ntse nce nyob rau hauv cov tib neeg noj qab haus huv, kev cuam tshuam rau me ntsis kev txawj ntse, thiab kev tshawb fawb neuroscience. Ntau xyoo ntawm daim ntawv thov tau lees paub nws qhov zoo ntawm kev ua tau zoo, kev nyab xeeb, thiab tsis muaj kev quav yeeb quav tshuaj. Cov txheej txheem kev sib xyaw thiab kev ua kom huv huv thiab cov txheej txheem nruj nruj tau tsim nws txoj haujlwm tseem ceeb hauv kev ua haujlwm ntawm nootropic active tshuaj cov khoom xyaw.
Xi'an Faithful BioTech Co., Ltd. muab cov thev naus laus zis ntau lawm nrog cov txheej txheem kev lees paub zoo los muab siab - zooDM-235 hmoovuas ua tau raws li cov qauv tshuaj thoob ntiaj teb. Peb tau cog lus tias yuav muab cov nqi sib tw thiab kev txhawb nqa kev qhia dav dav, ua rau peb tus khub nyiam rau cov tsev kho mob thiab cov kws tshawb fawb thoob ntiaj teb. Thov hu rau peb pab neeg technical (allen@faithfulbio.com) kom paub seb peb cov khoom tuaj yeem txhim kho koj cov qauv li cas.
Cov ntaub ntawv
- Ghelardini, C., et al. (2002). DM235 (sunifiram): ib qho tshiab nootropic nrog lub peev xwm ua kev paub txog kev txawj ntse. Naunyn-Schmiedeberg's Archives of Pharmacology, 365(6), 419-426.
- Galeotti, N., et al. (2003). AMPA- receptor activation yog koom nrog cov nyhuv antiamnesic ntawm DM 232 (unifiram) thiab DM 235 (sunifiram). Naunyn-Schmiedeberg's Archives of Pharmacology, 368(6), 538-545.
- Fisher Scintific. Sunifiram, MedChemExpress (Product Code 16419867).
- (2022). Novel Sunifiram-carbamate hybrids li muaj peev xwm dual acetylcholinesterase inhibitor thiab NMDAR co-agonist. Phau ntawv Journal of Enzyme Inhibition thiab Medicinal Chemistry, 37(1), 1241-1256.
- Moriguchi, S., et al. (2013). Novel nootropic tshuaj sunifiram txhim kho kev txawj ntse ntawm CaM kinase II thiab protein kinase C ua kom muaj zog hauv cov nas olfactory bulbectomized. Behavioral Brain Research, 242, 150-157.